Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 272 (RN7SKP272) is a pseudogene sequence homologous to the functional 7SK small nuclear RNA (snRNA) gene. The parent RN7SK gene encodes a non-coding RNA involved in transcription regulation by controlling the activity of positive transcription elongation factor b (P-TEFb) and the elongation phase of RNA polymerase II-mediated transcription[1][3]. RN7SKP272 is a pseudogene, meaning it is a non-functional copy or derivative of the original RN7SK gene and, as such, does not encode a functional product and lacks known biological activity or therapeutic relevance[2]. Key notes for structured extraction: - RN7SKP272 is not a therapeutic target, receptor, enzyme, or gene with established biological or disease function. - It is a pseudogene: a sequence derived from the functional RN7SK locus but identified as defective, nonfunctional, or noncoding in the human genome. - Functional context relates to the parent 7SK RNA, which is important for transcriptional regulation, but this is NOT the case for RN7SKP272 itself[1][3]. This entry is provided for completeness and should be flagged as incorrect if the intention is to find therapeutic or functional targets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 272 (RN7SKP272).